Granza Bio

Granza Bio is a biotechnology company developing a cell-targeted delivery platform based on supramolecular attack particles, naturally occurring structures used by cytotoxic T cells and natural killer cells to deliver lethal payloads with precision.

The company is engineering programmable versions of these particles, loaded with therapeutic cargo such as proteins and nucleic acids, to enable precise delivery of cell and gene therapies to specific tissues.

Target applications include oncology, autoimmune disease, and genetic disease.